3 Biotechs That Have Doubled Investors' Money in Less Than a Year Post author:Sam Post published:January 22, 2018 Post category:BioPharma Having a stock double in value is a good thing. Source: BioSpace You Might Also Like AstraZeneca PLC Loses $10 Billion in Value as Long-Awaited MYSTIC Trial Disappoints July 26, 2017 Creative BioMart Launched A Series Of Activities And Promotions Recently March 19, 2017 Dermira’s Acne Medication Olumacostat Glaseretil Tanks in Two Phase III Trials March 4, 2018
